ArticleHealthcare technology letters2024
SpeechMatch-A novel digital approach to supporting communication for neurodiverse groups.
Article in Healthcare technology letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- SpeechMatch-A novel digital approach to supporting communication for neurodiverse groups.Healthcare technology letters · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Communication can be a challenge for a significant minority of the population. Those with intellectual disability, autism, or Stroke survivors can encounter significant problems and stigma in their communication abilities leading to worse health and social outcomes. SpeechMatch (https://www.speechmatch.com/) is a digital App which is a pragmatic mobile language training platform that teaches individuals to "match" critical components of conversation and looks to provides subjects with immediate visual feedback to shape identification and expression of emotion in speech. While it has been used in autistic people there has been no systematic exploration of its strengths and weaknesses. Further, it's potential to afford improvements in communication to other vulnerable groups such as intellectual disability or Stroke survivors has not been explored. This study looked to understand acceptability from people with intellectual disability and/or autism and those recovering from a stroke on the utility and scope of SpeechMatch using co-production techniques using experts by experience and a mixed methods evaluation. Results across four domains suggest high acceptability levels but highlighting needs for platform capabilities improvement and better user engagement. The study outlines a vital and essential aspect for improving SpeechMatch. It gives a template for evidenced based quality improvement of similar devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.